Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.

Aydin M. A., Gul G., Kiziltan R., Algul S., Kemik O.

European review for medical and pharmacological sciences, cilt.24, sa.20, ss.10512-10517, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 20
  • Basım Tarihi: 2020
  • Doi Numarası: 10.26355/eurrev_202010_23403
  • Dergi Adı: European review for medical and pharmacological sciences
  • Derginin Tarandığı İndeksler: Scopus, EMBASE, MEDLINE, Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.10512-10517
  • Anahtar Kelimeler: Colon cancer, NAP1L1, Marker, Early diagnosis, Risk stratification, Stage, Controls, COLORECTAL-CANCER
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

OBJECTIVE: To evaluate the diagnostic and prognostic utility of nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients.